Regents committee hears overview of systemwide research compliance, raises questions on AI and industry conflicts

The Audit and Compliance Committee of the University of Minnesota Board of Regents heard a systemwide overview of research compliance administration at its May 2025 meeting. Presenters named by the chair—Associate Vice President for Research Integrity and Compliance Joanne Billings and Danielle Uuntala, Director of Research Integrity and Compliance—detailed the units and processes that review and monitor human-subjects, animal, biosafety and sponsored research.

The presentation outlined the Research Integrity and Compliance (RIO) administrative structure and key units: the human-research protection program and IRB, the animal-care and use committee (IACUC), the institutional biosafety committee (IBC), export controls and research security, and sponsored-projects administration for grants and contracts. Billings and Uuntala emphasized that principal investigators, their teams and unit administrators share responsibility for implementing controls and training.

"Compliance often is presented as an expense. It's not an expense. We are the money saver," Uuntala said, characterizing compliance as protection against the costs of noncompliance. She added that the university coordinates reviews across multiple offices—including health, safety and risk management, institutional compliance, general counsel and internal audit—and relies on checklists and unit-specific review processes to determine which groups must weigh in on a protocol.

Committee members pressed presenters for a concrete example of how the review process works in practice. Billings described a hypothetical clinical trial workflow: initial non‑disclosure agreements with industry partners, sponsored‑projects administration handling budgets and contracts, IRB review for human participants, HIPAA or radiation‑safety reviews as needed, and continuing oversight after a study begins.

Regents also asked how the university maintains agility as technology and federal requirements change. Uuntala cited multi‑institution collaborations—Big Ten working groups and the Association of Research Integrity Officers—and frequent monitoring of federal rulemaking ("I get the Federal Register every morning") as mechanisms to track and implement evolving requirements. She cited a Council on Governmental Relations figure noted in the presentation that federal research requirements that applied years ago have grown markedly through 2024, increasing training and reporting burdens on researchers.

On conflicts of interest, presenters said an institutional conflicts committee reviews cases where the university has a potential financial stake (for example, patents or royalties) to determine whether the compelling reasons exist to conduct research locally. Presenters said individual conflicts-of-interest processes, managed by institutional compliance, are used to evaluate and manage faculty and investigator commitments.

The discussion closed with a committee member urging attention to how research is translated into practice—warning that compliance conversations should not obscure pathways for implementation—after which the chair thanked the presenters and opened the next agenda item.

The committee did not take formal action on the presentation; the topic was an informational briefing and will remain part of ongoing oversight and follow‑up as regulatory developments continue.